CCNE1 Amplification and Overexpression Characterizes Ovarian Clear Cell Carcinoma But Not Ovarian Endometrioid Carcinoma

被引：0
|
作者：
Ayhan, Ayse
Ogawa, Hiroshi
Bahadirli-Talbott, Asli
Wu, Ren-Chin
Sugimura, Haruhiko
Wang, Tian-Li
Shih, Ie-Ming
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[2] Seirei Mikatahara Hosp, Hamamatsu, Shizuoka, Japan
[3] Chang Gung Mem Hosp, Taoyuan, Taiwan
[4] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[5] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 4313192, Japan
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1092
引用
收藏
页码：273A / 274A
页数：2
相关论文
共 50 条
  • [31] The presence of clear cell glands around the ovarian endometrioid cyst has an association with clear cell carcinoma
    Jiani Qu
    Jing Yu
    Siyuan Zhong
    Wenchao Wang
    Qingping Wang
    Bin Du
    Virchows Archiv, 2023, 482 : 1021 - 1034
  • [32] Characterizing intratumoral heterogeneity of CCNE1 amplification in ovarian cancer using digital pathology
    Petrone, Adam
    Soria-Bretones, Isabel
    Johnson, Adrienne
    Sethuraman, Sunantha
    Silverman, Ian M.
    Reis-Filho, Jorge
    Marshall, Gary
    Veloso, Artur
    Aguado-Fraile, Elia
    Rimkunas, Victoria
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (06)
  • [33] Human Epidermal Growth Factor Receptor 2 Overexpression/Amplification in Primary Ovarian Endometrioid Carcinoma
    Bui, Chau M.
    Oren, Aviv
    Balzer, Bonnie
    Maluf, Horacio
    Medeiros, Fabiola
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2024, 32 (05) : 222 - 228
  • [34] CCNE1 is a potential target of Metformin for tumor suppression of ovarian high-grade serous carcinoma
    Mei, Jie
    Tian, Huixiang
    Huang, Hsuan-Shun
    Wu, Nayiyuan
    Liou, Yu-Ligh
    Chu, Tang-Yuan
    Wang, Jing
    Zhang, Wei
    CELL CYCLE, 2023, 22 (01) : 85 - 99
  • [35] The proteome of clear cell ovarian carcinoma
    Ji, Jennifer X.
    Cochrane, Dawn R.
    Negri, Gian Luca
    Colborne, Shane
    Miko, Sandra E. Spencer
    Hoang, Lynn N.
    Farnell, David
    Tessier-Cloutier, Basile
    Huvila, Jutta
    Thompson, Emily
    Leung, Samuel
    Chiu, Derek
    Chow, Christine
    Ta, Monica
    Kobel, Martin
    Feil, Lucas
    Anglesio, Michael
    Goode, Ellen L.
    Bolton, Kelly
    Morin, Gregg B.
    Huntsman, David G.
    JOURNAL OF PATHOLOGY, 2022, 258 (04): : 325 - 338
  • [36] The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis
    Chene, Gautier
    Ouellet, Veronique
    Rahimi, Kurosh
    Barres, Veronique
    Provencher, Diane
    Mes-Masson, Anne Marie
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2015, 130 (01) : 27 - 30
  • [37] THE ARID 1A PATHWAY IN OVARIAN CLEAR CELL AND ENDOMETRIOID CARCINOMA, IN CONTIGUOUS ENDOMETRIOSIS AND IN BENIGN ENDOMETRIOSIS
    Chene, G.
    Ouellet, V.
    Rahimi, K.
    Barres, V.
    Caceres, K.
    Meunier, L.
    Cyr, L.
    De ladurantaye, M.
    Provencher, D.
    Masson, A. M. Mes
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 959 - 960
  • [38] CCNE1 amplification in high-grade serous ovarian cancer: analysis of the GENIE database
    Al-Akhras, Ashaar
    Tashtoush, Shaden
    Ghazou, Alina
    CANCER RESEARCH, 2023, 83 (07)
  • [39] L1CAM expression associates with poor outcome in endometrioid, but not in clear cell ovarian carcinoma
    Soovares, Piret
    Pasanen, Annukka
    Butzow, Ralf
    Lassus, Heini
    GYNECOLOGIC ONCOLOGY, 2017, 146 (03) : 615 - 622
  • [40] Frequency and clinical features of deficient mismatch repair in ovarian clear cell and endometrioid carcinoma
    Tanaka, Tamaki
    Takehara, Kazuhiro
    Yamashita, Natsumi
    Okazawa-Sakai, Mika
    Kuraoka, Kazuya
    Teramoto, Norihiro
    Taguchi, Kenichi
    Yamashiro, Katsushige
    Kato, Hidenori
    Mizunoe, Tomoya
    Suzuki, Rie
    Yamamoto, Dan
    Ueki, Arisa
    Saito, Toshiaki
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2022, 33 (05)
12345